Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey. | Antimicrob Agents Chemother;43(3): 503-9, 1999 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.

Fielding, R M; Moon-McDermott, L; Lewis, R O; Horner, M J.

Affiliation

Fielding RM; NeXstar Pharmaceuticals, Inc., Boulder, Colorado. biopharm@worldnet.att.net

Antimicrob Agents Chemother ; 43(3): 503-9, 1999 Mar.

Article in En | MEDLINE | ID: mdl-10049258

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 1999 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 1999 Document type: Article Country of publication: